FDA DrugClass IINotable

FDA Recall: Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC

Date: 2026-07-08
Brand: Cipla USA, Inc.
Category: Drug
FDA Class: Class II

Description

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Hazard

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Remedy

N/A

View original recall →
Share:

Related Recalls

2026-07-08 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC
Cipla USA, Inc.
2026-07-08 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC
Cipla USA, Inc.
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.